Striatal volume deficits in children with ADHD who present a poor response to methylphenidate

Area of Science:

• Neuroscience
• Child and Adolescent Psychiatry
• Radiology

Background:

• Methylphenidate (MPH) is a primary pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD).
• A significant portion of ADHD patients (10-30%) exhibit inadequate response to MPH.
• Understanding predictors of MPH response is crucial for optimizing ADHD treatment.

Purpose of the Study:

• To investigate potential neuroanatomical differences in the striatum between children with ADHD who respond well versus poorly to MPH.
• To explore the relationship between striatal gray matter volume and treatment outcomes in pediatric ADHD.

Main Methods:

• Magnetic Resonance Imaging (MRI) was used to analyze brain structure in 27 treatment-naïve children (ages 6-14) with ADHD.
• Region of interest (ROI) analysis focused on the caudate and accumbens nuclei.
• Clinical response to MPH was assessed after one month of treatment using established criteria.

Main Results:

• Children who were good responders to MPH showed significantly higher gray matter concentration in the head of the caudate nuclei and the right nucleus accumbens compared to poor responders.
• A positive correlation was observed between the volumes of the caudate and accumbens nuclei and improvements in ADHD symptom severity, as measured by the Conners' Parent Rating Scale and Continuous Performance Test.

Conclusions:

• These findings suggest that the caudate and accumbens nuclei play a role in the neurobiological mechanisms underlying MPH response in children with ADHD.
• Striatal gray matter volume may serve as a potential neuroimaging biomarker for predicting MPH treatment outcomes in pediatric ADHD.